Related Experiment Video
Updated: Sep 9, 2025
06:58
Analysis of Interactions between Endobiotics and Human Gut Microbiota Using In Vitro Bath Fermentation Systems
Published on: August 23, 2019
7.2K
Starch-EGCG Complexes Improve Starch Fermentability, Acetate Production, and Alter Relations between Gut Microbiota
Jian Zhu1,2, Shaomin Zhu2, Wing Tak Wong1
1Food & Nutritional Sciences Programme, School of Life Sciences, The Chinese University of Hong Kong, Shatin 999077, Hong Kong, China.
Journal of Agricultural and Food Chemistry
|September 4, 2025
Summary
Green tea
Area of Science:
- Microbiology
- Nutritional Science
- Biochemistry
Background:
- Epigallocatechin gallate (EGCG), abundant in green tea, exhibits potential synergistic effects with starch.
- Starch-EGCG complexes are a form of type 5 resistant starch, but their impact on gut microbiota and starch chain-length distribution is not fully understood.
Purpose of the Study:
- To investigate the effects of starch-EGCG complexes on gut microbiota and short-chain fatty acid (SCFA) production.
- To analyze how different starch types influence these effects.
Main Methods:
- An in vitro fermentation model was employed to analyze five different starch-EGCG complexes.
- Microbial composition and SCFA profiles were analyzed.
Main Results:
- All starch-EGCG complexes significantly increased gas and SCFA production.
- Pea starch-EGCG complex maximized acetate, while chestnut and cassava complexes notably produced propionate and butyrate, respectively.
- Corn starch-EGCG complex significantly elevated Prevotella abundance, and a slowly fermentable starch fraction (peak DP ~65) remained unaffected by EGCG.
Conclusions:
- Starch-EGCG complexes differentially modulate gut microbial communities and SCFA profiles.
- These findings suggest potential for targeted gut health interventions using starch-EGCG complexes.
More Related Videos
Related Concept Videos
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
255
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
255
00:57Carbohydrate Digestion
117.3K
Carbohydrate digestion and metabolism break down simple and complex carbohydrates from food into saccharides (i.e., sugars) for the body to use as energy. Carbohydrate digestion starts in the mouth during mastication, or chewing. The masticated carbohydrates remain intact in the stomach. Digestion resumes in the duodenum of the small intestine, where pancreatic alpha-amylase and brush border enzymes of the microvilli convert complex carbohydrates to monosaccharides. Finally, the monosaccharides...
117.3K